Disrupted sensory interhemispheric synchronization in schizophrenia: a frequency-resolved VMHC analysis

BackgroundAberrant interhemispheric functional connectivity has been implicated in the pathophysiology of schizophrenia. Voxel-mirrored homotopic connectivity (VMHC) provides a reliable measure of interhemispheric synchronization, yet the frequency-specific characteristics of VMHC alterations in schizophrenia remain poorly understood.MethodsResting-state functional magnetic resonance imaging data were analyzed in patients with schizophrenia and matched healthy controls. VMHC was computed across frequency bands, with particular focus on slow-4 and slow-5 oscillations. Group differences, as well as group-by-frequency interactions, were assessed to identify frequency-specific disruption.ResultPatients with schizophrenia exhibited significantly reduced VMHC within key sensory networks, including primary visual and sensorimotor regions. Frequency-specific analyses revealed higher VMHC at slow-5 compared with slow-4 in visual gyrus and subcortical regions. Significant group-by-frequency interaction effects were observed in the middle occipital gyrus and postcentral gyrus, with post-hoc analyses indicating selectively reduced slow-4 VMHC in patients with schizophrenia.ConclusionThis study demonstrates frequency-dependent reductions of interhemispheric connectivity in schizophrenia, particularly within sensory systems. The findings highlight the disrupted integration of primary perceptual and motor-related processes as a core feature of schizophrenia and emphasize the utility of frequency-resolved VMHC analyses for refining our understanding of network dysfunction. Future longitudinal studies are warranted to determine the clinical significance of these frequency-specific alterations in illness progression and treatment response.

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

Conditions: Early Onset Psychosis; First Psychotic Episode Within the Last 5 Years; First-episode Psychosis; Schizophrenia Spectrum Disorders (SSD); Psychosis; Psychosis NOS; Randomized Controlled Trial (RCT)

Interventions: Behavioral: FEEL GOOD; Other: Treatment as Usual (TAU)

Sponsors: Stephanie Mehl; German Research Foundation; Universitätsklinikum Hamburg-Eppendorf; Central Institute of Mental Health, Mannheim; University Hospital Augsburg; Ludwig-Maximilians – University of Munich; Charite University, Berlin, Germany; University Hospital of Cologne; Vivantes Klinikum am Urban; Philipps University Marburg

Recruiting

Higher Vitamin C Levels in Blood Linked to Healthier Aging Brains

Researchers in Japan have found that older adults with higher levels of vitamin C in their blood have a higher volume of gray matter in their brains and higher connectivity across brain regions involved in memory and attention. Published in PLOS One, their study raises the possibility of using dietary interventions to protect brain health as we age. 

“What I found most fascinating about this research is that we were able to detect these subtle but significant associations between a single nutritional factor and large-scale brain networks by utilizing a robust, community-based cohort of over 2,000 older adults,” said Tomohiro Shintaku, MD, PhD, assistant professor of radiology at the Hirosaki University Graduate School of Medicine. “It truly highlights the potential impact of our everyday dietary habits on our brain structures.”

Previous research had linked diets high in vitamin C with lower risk of developing cognitive impairment in older adults. However, this study is the first to look directly at a potential link between vitamin C levels in blood and changes in brain structure and connectivity within a large participant cohort. 

Shintaku and colleagues analyzed magnetic resonance imaging (MRI) scans and blood levels of vitamin C in 2,044 Japanese adults over the age of 64. They measured the volume of gray and white brain matter in each individual, as well as the connectivity between brain regions belonging to the default mode network, which are associated with important cognitive functions including autobiographical memory, future thinking, self-reference, and attention. Connectivity within the default mode network is also known to play a significant role in brain health, with lower connectivity being linked to cognitive impairment and Alzheimer’s disease, in addition to a number of psychiatric conditions including depression or schizophrenia. 

After adjusting for other factors that affect brain structure and connectivity, such as age, physical activity, and education level, results showed that higher levels of vitamin C were associated with a higher volume of gray matter across several brain regions, and with higher connectivity within the default mode network. 

“Our study demonstrates that higher plasma vitamin C levels are associated with better preserved structural connectivity of the default mode network, a key brain network involved in cognitive function,” said Shintaku. “This finding generates the exciting hypothesis that a diet rich in vitamin C might play a supportive role in maintaining brain health and mitigating age-related cognitive decline in older adults.”

More research will be needed to uncover the potential biological mechanisms driving this association and confirm whether there is a causal link between blood levels of vitamin C and changes in brain structure and connectivity. Going forward, the researchers plan to conduct studies looking at repeated measurements of vitamin C levels over time, accounting for additional lifestyle and nutritional factors that may influence these effects, and including cohorts with more diverse ethnicities and socioeconomic status. 

The post Higher Vitamin C Levels in Blood Linked to Healthier Aging Brains appeared first on Inside Precision Medicine.

TARGA Imager Enables High-Resolution Imaging of Neurodevelopmental Models

Sponsored content brought to you by

Lumencor logo

Neurodevelopment in schizophrenia poses major challenges for experimental study due at least in part to the brain’s genetic complexity, cellular diversity, and limitations in accessing living human tissue. To overcome such barriers, researchers often use complementary human stem cell–derived models: adherent cortical organoids and Neurogenin-2 (NGN2) induced neurons. Adherent cortical organoids form three-dimensional cultures containing diverse cortical neuron types, enabling analysis of network development and long-term maturation over months.1 In contrast, NGN2 neurons generate rapid, two-dimensional, homogeneous populations of excitatory neurons that display robust activity within weeks, making them well suited for scalable, functional assays, and high-throughput screening.2

With the added insight that stem cell models offer into the neural development of the schizophrenic brain, the quantification of patient-derived neurons’ collective function is a priority.3 At Columbia University’s Mortimer B. Zuckerman Mind Brain and Behavior Institute, researchers use NGN2 neurons, yielding reproducible populations of excitatory cortical neurons that scale reliably across experiments.

Calcium imaging provides a powerful functional readout in these NGN2 neuron networks. When a neuron fires an action potential, voltage-gated calcium channels open and intracellular calcium rises sharply.4 Fluorescence calcium indicators convert transient, ionic changes into fluorescence emission that can be quantitatively detected via light microscopy across thousands of cells simultaneously. Coupling calcium-sensitive reporters with high-speed optical microscopy enables noninvasive, population-level measurement of neural activity, synchrony, and network dynamics. Interpreting these rich image sequences requires sophisticated theoretical and numerical approaches.5

Building on the ability to measure neural activity with calcium imaging at scale, Lumencor’s TARGA Imager represents a transformative step in the development of optical imaging hardware for the study of neurodevelopmental conditions such as schizophrenia. It is well suited to workflows where NGN2-neuron cultures are studied across multiple conditions in parallel (Figure 1). In these contexts, TARGA delivers calcium fluorescence images over millimeter-scale fields of view within standard 96-well plates, entire well areas, while maintaining high-speed, faster-than video rate imaging with precision resolution.

Lumencor NGN2-neurons calcium imaging workflow
Figure 1. TARGA implementation for NGN2-neurons calcium imaging workflow

These capabilities allow researchers to observe chemical communications across large neuronal networks rather than isolated cells in real time. Images can be acquired at frequencies up to 100 Hz, enabling capture of fast calcium transients of collective neuronal dynamics. Rapid switching of multicolor excitation light supports multiplexed fluorescence dyes, linking functional activity with cellular structure and organization.

Overall, TARGA achieves high spatial, temporal, and spectral resolution simultaneously with precise, automated opto-mechanical architecture. These data are well matched to modern image analysis and AI algorithms, generating robust fluorescence traces from complex neuronal populations (Figure 2). In combination, these features make the TARGA Imager a revelatory neuroscience tool, uniquely enabling visualization of emergent collective behavior at millimeter scale with exceptional resolution. Such integrated performance accelerates discovery by bridging cellular mechanisms and systems-level phenotypes relevant to schizophrenia pathophysiology and therapeutic screening. By uniting scale, speed, and precision in a single optical platform, TARGA empowers researchers to probe experimental neuroscience and strengthens translational studies of complex psychiatric disease at population scale.

NGN2-neurons calcium imaging workflow
Figure 1. TARGA implementation for NGN2-neurons calcium imaging workflow

 

References

  1. Van der Kroeg et al. Human adherent cortical organoids in a multiwell format. eLife. 2024. 13:e98340.
  2. Shan et al. Fully defined NGN2 neuron protocol reveals diverse signatures of neuronal maturation. Cell Reports Methods. 2024. 4:100858.
  3. Rao et al. Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome‑associated schizophrenia. Nature Communications. 2025. 16:6986.
  4. Zhang et al. Fast and sensitive GCaMP calcium indicators for imaging neural populations. Nature. 2023. 615:884–891.
  5. Pasarkar et al. maskNMF: A denoise‑sparsen‑detect approach for extracting neural signals from dense imaging data. bioRxiv. 2023. 2023.09.14.557777.

 

Lumencor_June 2026 sponsored content QRCode

 

To learn more, visit: lumencor.com or contact our team at: info@lumencor.com.

The post TARGA Imager Enables High-Resolution Imaging of Neurodevelopmental Models appeared first on Inside Precision Medicine.

Diazepam combined with aripiprazole in the treatment of a catatonic stupor patient with venous thrombosis: a case report

BackgroundCatatonic stupor is a potentially life-threatening condition, with key symptoms including mutism, immobility, refusal to eat, and negativism. It may be accompanied by complications such as infection, hyperthermia, and thrombosis. When patients develop concurrent severe physical illnesses, this is very likely to cause delays in diagnosis and treatment, further increasing the risk of clinical deterioration.MethodsThis article reports a 52-year-old patient with schizophrenia presenting with catatonic stupor and failure to establish effective communication. The uniqueness of this case is that the patient was admitted with concurrent pulmonary infection, pulmonary embolism, and lower limb deep venous thrombosis, and modified electroconvulsive therapy (MECT) was associated with substantial clinical risks. The patient was eventually treated with a combination of diazepam and aripiprazole. During treatment, the severity of the patient’s catatonic symptoms was assessed using the Bush-Francis Catatonia Rating Scale (BFCRS).ResultAfter combined treatment with diazepam and aripiprazole, the patient’s catatonic symptoms were relieved, and various functions gradually recovered. The BFCRS score reduction rate exceeded 70%, indicating that the expected therapeutic effect was achieved.ConclusionAs a relatively safe and effective intervention regimen, the combination treatment of diazepam and aripiprazole may be applicable to high-risk catatonic patients with relative contraindications to MECT, such as those complicated with venous thrombosis, providing a new therapeutic option for catatonic stupor.

Expressive writing combined with digital cognitive therapy in patients with schizophrenia: a narrative review of efficacy, linguistic phenotypes, and adherence modulators

Schizophrenia involves emotional and cognitive deficits that are often unresponsive to medication, emphasizing the need for effective psychosocial rehabilitation. This narrative review and conceptual perspective explores the potential integration of expressive writing (EW) and digital cognitive therapy (DCT) as a proposed dual approach to support emotional regulation and cognitive recovery. EW can facilitate emotional processing and motivation, while digital therapy may improve attention, memory, and executive function through structured and interactive training. Their proposed combination could promote engagement, strengthen self-efficacy, and support long-term rehabilitation. Linguistic analysis using natural language processing (NLP) could offer objective indicators of emotional and cognitive change, potentially enabling personalized and adaptive intervention. Overall, the proposed integration model may provide a practical and broadly implementable framework for improving functional prognosis and promoting recovery in schizophrenia, but empirical research is needed to determine its effectiveness, scalability, or clinical applicability, among other aspects.
<![CDATA[Blood exosomal microRNA markers reveal oxidative-stress subtypes, predict psychosis conversion, and guide early, targeted treatments like MitoQ.]]>

Treatment outcomes of an integrated treatment model for patients with co-occurring opioid use and schizophrenia spectrum disorders

BackgroundIndividuals with schizophrenia spectrum disorders are at elevated risk for developing opioid use disorder and often experience higher substance use rates and morbidity. However, integrated treatment models for such patients remain rare.ObjectiveThis study addresses a gap in clinical knowledge by evaluating outcomes from a dual-diagnosis program tailored for patients with both disorders.MethodsThis retrospective case series analyzed electronic medical record data from when patients were enrolled in the program through March 1st, 2025 or program discharge.ResultsSeventeen patients attended at least one appointment. All patients had a diagnosis of opioid use disorder. Co-occurring psychotic disorders included schizoaffective disorder (13/17, 76%), schizophrenia (3/17, 18%), and unspecified psychotic disorder (1/17, 6%). On average, patients attended 58.8% of scheduled visits, and 47.1% remained actively enrolled as of 3/1/25. Medication adherence was high, with patients taking prescribed medications for opioid use disorder at 90.5% of visits and antipsychotics at 96.9% of visits. Compared to an equivalent pre-enrollment period, patients showed a significant reduction in emergency department visits (P=0.00051) and inpatient hospitalizations (P=0.00090).ConclusionFindings suggest that the integrated treatment model could offer benefits for patients with co-occurring opioid use disorder/schizophrenia spectrum disorders; patients had significantly reduced emergency department visit frequency and frequency/duration of hospitalizations. Patients demonstrated high adherence to medications for opioid use disorder and antipsychotics; appointment attendance remains an area for improvement. Further research with larger samples and longer follow-up is warranted.